FOXP3 Antibodies

Forkhead Box P3 (FOXP3) has a molecular weight of approximately 47 kDa, primarily expressed in regulatory T cells (Tregs), a specialized subset of T lymphocytes involved in immune regulation. This protein is a transcription factor that plays a central role in the development and maintenance of Tregs by controlling the expression of genes that contribute to the suppressive function of these cells.

Mutations or deficiencies in FOXP3 are associated with immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, a rare autoimmune disorder. The dysregulation of Tregs and Forkhead Box P3 expression have also been implicated in various autoimmune diseases, allergies, and some cancers.

Antibodies against FOXP3 are used in research to identify and study Tregs. For example, immunohistochemistry and flow cytometry techniques employing anti-FOXP3 antibodies help researchers analyze Treg populations in tissues and blood samples.

Forkhead Box P3 is a potential biomarker in autoimmune diseases and cancer. Diagnostically, assessing its expression provides insights into the immune status of patients and could predict disease outcomes.

Synonyms

Forkhead box protein P3, AIID|DIETER|IPEX|JM2|PIDX|XPID

Research Areas

Apoptosis, Autophagy, Breast Cancer, Cancer, Cardiovascular, Cell Biology, Cellular Markers and Tags, Developmental Biology, Endocrine, Epigenetics, Gastrointestinal Tract, Hypoxia, Immuno Oncology, Immunology, Kidney, Lymphatic, Metabolism, Microbiology, Muscle, Neuroscience, Pancreatic Cancer, Prostate Cancer, Skin, Stem Cell, AKT Signaling, Angiogenesis, Articular Cartilage Extracellular Matrix, B Cell Markers, Basal Cell Marker, BBB VCAM-1 Signaling, Bladder Cancer, Cardiac Stem Cells, Colon Cancer, Colorectal Cancer, Complement System, CTLA-4 blockade immunotherapy, Cytokine Signaling, Defective Intrinsic Apoptosis, Dendritic Cell Marker, Digestion, Endothelial Cell Marker, Hematopoietic Stem Cells, Immune checkpoint, Infectious Disease, Lipid Metabolism, Lung Cancer, MAPK Signaling, Mast Cell Marker, Melanoma, Mesenchymal Stem Cell Differentiation, Mitochondria Marker, Neural Stem Cells, Neuroinflammation, Nuclear Marker, Oncology, Ovarian Cancer, PD-1 blockade immunotherapy, Signal Transduction, Stem Cell Differentiation, Transcription Factors